CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease The Print dated 20th December 2022

CMFRI, Library (2022) CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease The Print dated 20th December 2022. The Print.

[img]
Preview
 Text
The Print_20-12-2022.pdf
Download (111kB) | Preview
Official URL: https://theprint.in/india/cmfri-signs-mou-to-launc...
Related URLs:

    Abstract

    The Central Marine Fisheries Research Institute (CMFRI)has signed an MoU for the production of Cadalmin LivCure extract, a patent-protected nutraceutical product from seaweeds, to combat non-alcoholic fatty liver disease (NAFLD). A Memorandum of Understanding (MoU) was inked with Emineotech, a private limited company dealing with health products, for commercial production and marketing.

    Item Type: Article
    Subjects: CMFRI News Clippings
    Divisions: Library and Documentation Centre
    Depositing User: Mr. Augustine Sipson N A
    Date Deposited: 26 Dec 2022 04:30
    Last Modified: 26 Dec 2022 04:30
    URI: http://eprints.cmfri.org.in/id/eprint/16554

    Actions (login required)

    View Item View Item
    CMFRI Repository is hosted by Library and AKMU of Central Marine Fisheries Research Institute , Kochi